Key Points

• Illinois enacts sweeping cannabis and hemp reform. Senate Bill 3222 represents the most significant amendment to Illinois cannabis law since the Cannabis Regulation and Tax Act was enacted in 2019.
• New Illinois Hemp Act restricts intoxicating hemp sales and creates licensing framework. The Act effectively eliminates the sale of commercially viable intoxicating hemp products outside the licensed cannabis market.
• Licensed dispensaries gain drive-through service, extended hours and medical tax exemption. SB 3222 authorizes dispensary drive-throughs, extends operating hours to 2 a.m., relaxes security staffing requirements and creates a new Medical Cannabis Dispensing Organization License that exempts qualified patient purchases from the Cannabis Purchaser Excise Tax.

Illinois recently undertook the most significant amendment to the state’s cannabis law since the enactment of the Cannabis Regulation and Tax Act (CRTA) in 2019.

Senate Bill 3222 (SB 3222), which Governor J.B. Pritzker signed into law on June 12, 2026, addresses a broad range of issues affecting the cannabis and hemp industries, including intoxicating hemp products, dispensary operations, medical cannabis access, cultivation limits and enforcement authority.

Among other things, the sweeping 644-page bill creates a new regulatory framework for hemp-derived cannabinoid products, expands operational flexibility for licensed cannabis businesses, provides tax relief for medical cannabis patients and strengthens enforcement mechanisms directed at unlicensed market activity. Most provisions take effect upon the Governor’s signature. The Illinois Hemp Act, one of the bill’s most consequential components, takes effect on November 12, 2026. The Industrial Hemp Act is repealed on that same date.

The Illinois Hemp Act

One of the most consequential provisions in SB 3222 is the creation of the Illinois Hemp Act. The legislation establishes a comprehensive regulatory framework for hemp-derived cannabinoid products and significantly limits the sale of intoxicating hemp products outside Illinois’ licensed cannabis market.

For several years, products containing intoxicating cannabinoids have been widely available through smoke shops, convenience stores and other retailers operating outside the state’s regulated cannabis framework. SB 3222 addresses that market by imposing strict THC limits and creating a new licensing structure for hemp cultivation, processing and manufacturing.

The Act limits final consumer hemp cannabinoid products to 0.4 milligrams of total THC per container. It also prohibits synthetic and semi-synthetic cannabinoids and establishes classification lists that include Delta-8 THC, Delta-10 THC, HHC, HHCP, THCP, THC-O-Acetate and similar compounds, all of which count toward the statutory THC limit. Products exceeding that threshold are classified as cannabis and may only be sold through Illinois’ licensed cannabis supply chain. The Department retains authority to update those classifications through rulemaking as new cannabinoids emerge.

Products that remain lawful under the Act, which are expected to consist primarily of certain low-dose CBD products and topical formulations, must comply with testing, labeling and child-resistant packaging requirements that closely mirror those applicable to regulated cannabis products. The Department is also authorized to issue mandatory product recalls.

The legislation establishes escalating penalties for retailers that violate the Act. Fines begin at $500 and increase to $750 and $1,000 for subsequent violations. Violations are also designated unlawful practices under the Consumer Fraud and Deceptive Business Practices Act. In addition, the Act expressly preempts home rule units from adopting less restrictive hemp regulations, creating a uniform minimum statewide standard.

To implement this framework, the Act creates three separate license categories governing cultivation, processing and cannabinoid-product manufacturing.

Hemp Cultivation Licenses

A hemp cultivation license is required for any person cultivating hemp or industrial hemp in Illinois. Applicants must provide a legal description of the cultivation site, including GPS coordinates, and the Department is authorized to establish license terms, fees and renewal requirements through rulemaking.

The Department may conduct inspections, impose penalties of up to $10,000, and adopt testing standards for THC compliance. The Act also requires a retesting option for certain minor violations. Existing cultivation licensees operating under the Industrial Hemp Act may continue operating through the remainder of their current license term.

Industrial Hemp Processor Registrations

The Act creates an industrial hemp processor registration for entities that process raw hemp into non-cannabinoid products such as fiber, textiles, paper products and construction materials. Registrants may not manufacture products containing cannabinoids, and violations may result in revocation of the registration. The registration is valid for two years and carries a $200 fee. Existing registrants under the Industrial Hemp Act must obtain the new registration, but may seek a prorated refund.

Hemp Product Manufacturer Licenses

The hemp product manufacturer license applies to entities producing products that contain cannabinoids. The license requires a $5,000 fee, which is waived for public universities, and is issued on a facility-specific basis. Applicants must verify compliance with local zoning requirements and complete a Department inspection before licensure.

Licensed manufacturers may source hemp only from USDA-authorized growers or approved state and tribal programs and may not produce artificially derived cannabinoids. Operations must be supervised by a Department of Public Health-certified food service sanitation manager and must comply with the Illinois Food, Drug and Cosmetic Act.

The most extensive regulatory requirements apply to cannabinoid extraction activities. Manufacturers seeking to conduct extraction must obtain separate Department approval, disclose extraction methods and chemicals used, undergo annual inspection by a professional engineer and comply with applicable NFPA, IFC, ASME and UL standards. Violations may result in penalties of up to $10,000.

Dispensary Operations: Drive-Throughs, Extended Hours and Relaxed Security

For licensed cannabis dispensaries, SB 3222 removes the prior prohibition on dispensary drive-throughs and expressly authorizes licensed dispensaries to offer pickup and drive-through services for cannabis products. The legislation also expands the definition of a pickup location to include sidewalks and parking lots contiguous to dispensary property. Age verification through an electronic scanning device remains mandatory.

The legislation also clarifies transportation rules for consumers. New subsection 15-85(e) provides that the statutory requirement that cannabis remain inaccessible during transport does not apply to cannabis that is lawfully purchased and maintained in its original sealed, child-resistant packaging. As a practical matter, the amendment provides additional clarity regarding the transportation of cannabis following a lawful retail purchase, including purchases made through a drive-through location.

SB 3222 also expands permissible dispensary operating hours. The original law generally limited operations to between 6 a.m. and 10 p.m. The amended statute permits operations from 6 a.m. until 2 a.m., subject to applicable local zoning requirements.

The legislation further modifies security requirements. Rather than requiring dispensaries to contract with a licensed security firm, the amended law requires operators to maintain on-site security guards. This change provides greater flexibility in how security services are staffed and managed and may reduce compliance costs for some operators.

Conditional dispensary license holders also receive additional flexibility. Prior law required the Department to rescind a conditional license if the holder failed to become operational within the applicable statutory timeframe. Under the amended provisions, the Department may consider the totality of the circumstances and either rescind the license or establish a new operational deadline. The change may be particularly relevant for conditional license holders that have experienced delays related to financing, site acquisition, zoning approvals or construction.

Cannabis Access and Tax Relief

New Section 15-37 creates a Medical Cannabis Dispensing Organization License, which becomes available 90 days after the bill is signed into law to entities holding adult-use dispensary licenses. The medical license must remain co-located with the corresponding adult-use license and may not be transferred independently. The new licensing structure facilitates one of the legislation’s most significant changes for patients. Purchases made by qualified patients, caregivers, Opioid Alternative Program participants and provisional patients from a licensed medical dispensing organization are exempt from the Cannabis Purchaser Excise Tax. This change also comes amid ongoing federal efforts to reconsider cannabis scheduling under the Controlled Substances Act.

Adult-use excise tax rates remain unchanged at 10 percent for products containing 35 percent THC or less, 25 percent for products containing more than 35 percent THC and 20 percent for infused products. As a result, qualified patients purchasing products through a medical dispensing organization may realize significant tax savings, particularly on products subject to the higher excise tax rates. The legislation also removes the prior requirement that patients purchase from a single designated dispensary. Patients may now obtain medical cannabis from any dispensary holding a Medical Cannabis Dispensing Organization License anywhere in the state.

Craft Grower Expansion and Supply Chain Changes

SB 3222 significantly expands cultivation capacity for Illinois craft growers. The legislation increases the maximum flowering canopy from 5,000 square feet to 14,000 square feet. The Department retains authority to approve additional canopy increases in 3,000-square-foot increments based on market conditions and a licensee’s compliance history.

The legislation also creates a new “processor organization” license for standalone extraction and manufacturing facilities. For the first time, cannabis processing activities may be conducted independently of cultivation and infuser operations, creating a pathway for businesses focused exclusively on manufacturing and extraction. In addition, new Section 40-50 authorizes cannabis transporter storage sites. Licensed transporters may maintain up to five secure, non-retail storage facilities to support logistics and distribution operations. Retail sales, processing and repackaging activities remain prohibited at these locations.

Expanded Enforcement Authority

SB 3222 substantially expands enforcement mechanisms directed at unlicensed cannabis sales and hemp-related violations. Civil penalties now reach $10,000 per violation for individuals or businesses engaged in unlicensed cannabis sales, with each day constituting a separate offense. The Department of Agriculture receives parallel enforcement authority, and administrative penalty orders may be enforced as judgments.

The legislation also designates violations of the Illinois Hemp Act as unlawful practices under the Consumer Fraud and Deceptive Business Practices Act. This creates additional enforcement avenues and expands the range of remedies available to regulators. Local governments are likewise authorized to adopt and enforce ordinances addressing violations within their jurisdictions. Taken together, these provisions reflect a significant effort to bring intoxicating hemp products and unlicensed cannabis activity within a more comprehensive regulatory and enforcement framework.

Implications for Industry Participants

Licensed Dispensaries

Licensed dispensaries are likely to be among the most immediately affected stakeholders. The authorization of drive-through operations, expanded operating hours and more flexible security requirements provide operators with additional tools to manage customer access and day-to-day operations. The creation of the Medical Cannabis Dispensing Organization License may also present new opportunities for dispensaries seeking to serve qualified medical patients. Because purchases made through a licensed medical dispensing organization are exempt from the Cannabis Purchaser Excise Tax, some operators may experience increased participation in the medical cannabis program once licenses become available. At the same time, dispensaries should continue to evaluate local zoning requirements and operational considerations, as municipal approval may still be necessary for certain business changes, including drive-through operations.

Craft Growers and Cultivators

The increase in allowable craft grower canopy from 5,000 square feet to 14,000 square feet represents a significant expansion of potential production capacity. Although additional canopy increases remain subject to Department approval, the amended statute provides qualifying craft growers with a clearer pathway for future expansion. The new processor organization license may also create opportunities for businesses focused on extraction, manufacturing and other processing activities that do not wish to maintain a cultivation footprint. The combination of expanded canopy limits and standalone processing licenses may contribute to greater specialization within Illinois’ licensed cannabis market. The canopy expansion from 5,000 to 14,000 square feet is transformative — but approval occurs in 3,000-square-foot increments at the Department's discretion. The new processing organization license creates opportunities for contract manufacturing specialists to enter without a cultivation footprint. Further, the craft grower canopy cap gives smaller cultivators room to scale.

Hemp and CBD Businesses

For companies currently selling intoxicating hemp products, SB 3222 is existential. The 0.4 mg total THC per-container ceiling eliminates any commercially viable intoxicating product. The November 12, 2026 effective date provides a window — but companies face a hard choice: (1) reformulate to comply (viable for CBD topicals, not for anything marketed as intoxicating); (2) obtain a hemp product manufacturer license ($5,000, facility inspection, zoning and food safety compliance); or (3) exit. The home rule preemption floor means no municipal safe harbor exists. Companies in this space should consult counsel immediately.

For businesses currently selling intoxicating hemp-derived cannabinoid products, SB 3222 introduces substantial new regulatory requirements. The Act’s 0.4 milligram total THC limit, combined with restrictions on synthetic and semi-synthetic cannabinoids, significantly narrows the range of products that may continue to be sold outside the licensed cannabis market. Businesses operating in this space may need to evaluate whether existing products can be reformulated to comply with the new framework, whether additional licensure will be required or whether broader operational changes will be necessary before the Illinois Hemp Act becomes effective on November 12, 2026, the same day a similar federal law prohibition takes effect.

Medical Cannabis Patients

Medical cannabis patients may benefit from several of the legislation’s most significant changes. The excise tax exemption may result in meaningful savings, particularly for patients purchasing products subject to higher adult-use tax rates. Together, these changes expand patient flexibility while preserving a distinct medical cannabis framework within Illinois’ broader adult-use market.

As implementation proceeds and agencies begin the rulemaking process, industry participants should closely monitor regulatory developments and assess how the legislation may affect existing operations, compliance obligations and future business opportunities.

For more information, please contact Akshay Krishnamani at 312.276.1328 or akrishnamani@foxrothschild.com, or another member of Fox Rothschild’s national Cannabis Law Practice Group.

This information is intended to inform firm clients and friends about legal developments, including the decisions of courts and administrative bodies. Nothing in this alert should be construed as legal advice or a legal opinion. Readers should not act upon the information contained in this alert without seeking the advice of legal counsel. Views expressed are those of the authors and not necessarily this law firm or its clients.